Kabanat - Cabazitaxel Injection

Kabanat - Cabazitaxel Injection

70-100 USD ($)/Pack

Product Details:


Kabanat - Cabazitaxel Injection Price And Quantity

  • 70.00 - 100.00 USD ($)/Pack
  • 70-100 USD ($)/Pack
  • 1 Pack

Kabanat - Cabazitaxel Injection Product Specifications

  • as per pack
  • Other

Kabanat - Cabazitaxel Injection Trade Information

  • Telegraphic Transfer (T/T)
  • 10000 Pack Per Day
  • 24 Hours
  • Yes
  • Free samples available with shipping and taxes paid by the buyer
  • as per pack
  • Western Europe Eastern Europe Central America Middle East South America Asia North America Australia Africa
  • All India
  • as per availability

Product Description

A chemotherapeutic drug called Kabanat (Cabazitaxel Injection) is used to treat metastatic castration-resistant prostate cancer (mCRPC) in individuals whose condition has gotten worse after having docetaxel-based treatment. A microtubule inhibitor called cabasitaxel prevents cancer cells from dividing and growing. Usually, the injection is given intravenously. Patients with mCRPC have a successful therapy option in Kabanat, which helps to reduce the disease's course and increase overall survival. However, it could result in negative side effects such peripheral neuropathy, tiredness, diarrhoea, and bone marrow suppression. To successfully manage potential side effects and improve treatment outcomes, close monitoring and appropriate supportive care are crucial during treatment.


Features and advantages of Kabanat (injection of cabazitaxel):

1. Effective in Advanced Prostate Cancer: Kabanat is a good treatment option for patients with metastatic castration-resistant prostate cancer (mCRPC) that has advanced following docetaxel-based therapy.

2. Microtubule Inhibitor: Cabazitaxel, a microtubule inhibitor, prevents the division and proliferation of cancer cells, which shrinks tumours and slows the spread of the disease.

3. A precise and regulated delivery of the injection is made possible via intravenous administration.

4. Improved Overall Survival: Patients with mCRPC have shown Kabanat to be beneficial in extending overall survival.

5. As a second-line chemotherapy option when docetaxel-based therapy has failed, it is known as second-line therapy.

6. Clinical Efficacy: Kabanat has demonstrated clinical efficacy in both real-world applications and clinical trials, solidifying its position as a critical therapy for mCRPC.

7. Although side effects are possible, Kabanat is typically well tolerated, and in carefully chosen patients, its advantages frequently outweigh its drawbacks.

8. Treatment Persistence: Kabanat enables patients whose cancer has advanced despite prior therapies to continue receiving treatment and managing their condition.

9. Treatment Plan Individualization: Kabanat offers a treatment plan that is tailored to each patient's unique medical condition and reaction to previous treatments.

10. Experienced usage: Kabanat has a long history of clinical usage and a proven safety and efficacy profile for the treatment of mCRPC.


In general, Kabanat (Cabazitaxel Injection) represents a substantial improvement in the management of metastatic castration-resistant prostate cancer by offering a potent therapeutic alternative for patients whose disease has progressed following docetaxel-based therapy. It is a crucial part of the mCRPC therapeutic landscape due to its capacity to increase overall survival and offer ongoing disease management. Kabanat should be taken under the guidance of skilled medical specialists who can carefully monitor its effects and appropriately manage any potential adverse effects, nevertheless, as with any chemotherapy drug. To guarantee the best possible treatment results and patient safety, regular monitoring and supportive care are crucial during treatment.


Kabanat (Cabazitaxel Injection) uses include:

1. Kabanat is primarily used to treat metastatic castration-resistant prostate cancer (mCRPC) in patients whose illness has advanced following docetaxel-based therapy.

Kabanat (Cabazitaxel Injection) side effects include:

1. Cabazitaxel can inhibit the activity of the bone marrow, which lowers the amount of blood cells produced and raises the risk of anaemia, infections, and bleeding.

2. Neutropenia: It can result in a considerable drop in the number of white blood cells, especially neutrophils, which raises the risk of infections.

3. Anaemia: Cabazitaxel may cause a reduction in red blood cells, which can result in anaemia and its accompanying symptoms, including weariness and weakness.

4. Thrombocytopenia: This condition may result in a drop in platelet counts, which raises the risk of bleeding and bruising.

5. Diarrhoea: Cabazitaxel frequently causes diarrhoea as a side effect.

6. Peripheral neuropathy: In some patients, nerve injury may result in symptoms including tingling, numbness, or weakness in the hands and feet.

7. Weakness and fatigue are frequent adverse effects that some people experience.

8. Cabazitaxel may make some individuals feel nauseous and sick to their stomachs.

9. Hair Loss: Alopecia, or temporary hair loss, is one of Cabazitaxel's potential adverse effects.

10. Hypersensitivity responses: In a small percentage of people, the medicine can cause life-threatening allergic responses.

11. GI Disturbances: It may result in stomatitis, an inflammation of the oral mucous membranes that can cause ulcers and discomfort.


Under the care of skilled medical personnel who can carefully monitor its effects and skillfully manage any potential side effects, patients should take Kabanat (Cabazitaxel Injection). The medical staff should be consulted before using Kabanat, and the patient's unique medical condition and personal risk factors should be taken into account. Throughout treatment, it is crucial to regularly check blood cell counts, kidney function, and patient safety. To treat bone marrow suppression and lower the risk of problems, proper supportive care can be used, such as the use of growth factor medicines. 

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Anti Cancer Injection' category

Back to top